Your browser doesn't support javascript.
loading
Prevention of preterm delivery: current challenges and future prospects.
van Zijl, Maud D; Koullali, Bouchra; Mol, Ben Wj; Pajkrt, Eva; Oudijk, Martijn A.
Afiliação
  • van Zijl MD; Department of Obstetrics and Gynaecology, Academic Medical Center, Amsterdam, the Netherlands.
  • Koullali B; Department of Obstetrics and Gynaecology, Academic Medical Center, Amsterdam, the Netherlands.
  • Mol BW; The Robinson Research Institute, School for Reproductive Health and Pediatrics, University of Adelaide, Adelaide, SA, Australia.
  • Pajkrt E; Department of Obstetrics and Gynaecology, Academic Medical Center, Amsterdam, the Netherlands.
  • Oudijk MA; Department of Obstetrics and Gynaecology, Academic Medical Center, Amsterdam, the Netherlands.
Int J Womens Health ; 8: 633-645, 2016.
Article em En | MEDLINE | ID: mdl-27843353
Preterm birth (PTB), defined as delivery at <37 weeks of gestation, is the most important cause of neonatal morbidity and mortality. Therefore, preventing PTB is one of the main goals in obstetric care. In this review, we provide an overview of the current available literature on screening for risk factors for PTB and a summary of preventive strategies in both low-risk and high-risk women with singleton or multiple gestations. Furthermore, current challenges and future prospects on PTB are discussed. For an optimal prevention of PTB, risk stratification should be based on a combination of (maternal) risk factors, obstetric history, and screening tools. Cervical length measurements can help identify women at risk. Thereafter, preventive strategies such as progesterone, pessaries, and cerclage may help prevent PTB. Effective screening and prevention of PTB vary between the different pregnancy populations. In singleton or multiple pregnancies with a short cervix, without previous PTB, a pessary or progesterone might prevent PTB. In women with a (recurrent) PTB in the past, progesterone and a cerclage may prevent recurrence. The effect of a pessary in these high-risk women is currently being studied. A strong collaboration between doctors, patients' organizations, pharmaceutical companies, and (international) governments is needed to reduce the morbidity and mortality as a result of spontaneous PTB.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Int J Womens Health Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Int J Womens Health Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda